Which medication is better for someone with heart disease
Mechanism: Targets GLP-1, GIP, and glucagon receptors
More substantial benefits including consistent deep sleep enhancement, comprehensive sleep architecture optimization, and robust recovery improvements typically develop over 1-4 weeks as circadian rhythms stabilize and sleep patterns normalize
Clinical trial data in humans indicate that exenatide or liraglutide may have a role in the treatment of T2DM as monotherapy or in addition to oral antidiabetic drugs
, 217 , 2291-2298, doi: Galadari, S., Rahman, A., Pallichankandy, S., and Thayyullathil, F
Coperchini, F., Chiovato, L., Croce, L., Magri, F